HEALTHCOURTHOUSE NEWS
Guts may hold the key to happiness
New research on mouse gut microbiomes suggests GLP-1 drugs like Ozempic may reduce depression and anxiety symptoms by altering gut bacteria, specifically increasing Lactobacillus delbrueckii, which produces stress-calming compounds. The study highlights a brain-gut connection linking these diabetes/weight-loss drugs to mood regulation.
Mentioned
Related Signal
Adjacent reporting
- Harvard scientists link gut bacteria to depression through hidden inflammation trigger
- Weight loss drug Ozempic linked to lower depression and anxiety risk
- Scientists discover hidden gut trigger behind ALS and dementia
- New depression treatment targets the immune system instead of the brain
- For the first time, scientists pinpoint the brain cells behind depression
- Scientists reverse anxiety by fixing a tiny brain circuit